Table II.

Presence of Elixhauser comorbidities in obese patients with and without metabolic syndrome.

Variable	Obese with MetS (n = 759,901), %	Obese without MetS (n = 985,141), %	p-value*
AIDS	0.01	0.03	0.0001
Alcohol abuse	0.97	1.00	0.2953
Deficiency anaemias	14.80	11.96	< 0.0001
Rheumatoid arthritis/collagen vascular diseases	3.34	3.88	< 0.0001
Chronic blood loss anemia	1.69	1.50	0.0001
Congestive heart failure	4.64	2.31	< .0001
Chronic pulmonary disease	19.95	18.23	< 0.0001
Coagulopathy	2.34	1.71	< 0.0001
Depression	17.13	16.05	< 0.0001
Diabetes, uncomplicated	53.67	6.61	< 0.0001
Diabetes with chronic complications	6.14	0.60	< 0.0001
Drug abuse	0.59	0.77	< 0.0001
Hypertension	96.94	58.27	< 0.0001
Hypothyroidism	17.45	15.86	< 0.0001
Liver disease	1.45	1.15	< 0.0001
Lymphoma	0.20	0.22	0.1638
Electrolyte disorders	11.23	7.84	< 0.0001
Metastatic cancer	0.07	0.09%	0.1476
Other neruological disorders	4.0	3.68	< 0.0001
Paralysis	0.27	0.20	< 0.0001
Peripheral vascular disorders	3.24	1.35	< .0001
Psychoses	2.85	2.65	0.0007
Pulmonary circulation disorder	1.58	1.14	< 0.0001
Renal failure	8.19	2.83	< 0.0001
Solid tumour without metastasis	0.41	0.32	< 0.0001
Peptic ulcer disease	0.02	0.01	0.3677
Valvular disease	3.93	2.76	< 0.0001

^*Chi-squared test.

MetS, metabolic syndrome.